Emmanuelle Samalin

2.1k citations

75 papers · 827 indexed · h-index 16

Impact in

Gastroenterology top 5%
- Gastrointestinal Tumor Research and Treatment
Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research

Papers in

Oncology 55
- Colorectal Cancer Treatments and Studies 32
- Cancer Treatment and Pharmacology 16
- Pancreatic and Hepatic Oncology Research 15
Gastroenterology 8

Co-authors: Marc Ychou Eric Assénat Fabienne Portales Simon Thézenas Thierry Conroy Michel Ducreux Céline Gavoille Julien Taı̈eb
Journals: Journal of Clinical Oncology (24 papers)Annals of Oncology (11 papers)Digestive and Liver Disease (6 papers)European Journal of Cancer (4 papers)Gastric Cancer (2 papers)
Partner nations: France Belgium United States

In The Last Decade

Emmanuelle Samalin

70 papers receiving 816 citations

Peers

Countries citing papers authored by Emmanuelle Samalin

Since Specialization

Citations

This map shows the geographic impact of Emmanuelle Samalin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuelle Samalin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuelle Samalin more than expected).

Fields of papers citing papers by Emmanuelle Samalin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuelle Samalin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuelle Samalin. The network helps show where Emmanuelle Samalin may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Emmanuelle Samalin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emmanuelle Samalin Line = papers co-authored together Emmanuelle Samalin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Trimodality therapy with carboplatin/paclitaxel (CP) or FOLFOX (FFX) for esophageal/esogastric junctional cancer (EC/EGJ): Expanded safety and efficacy data from PROTECT. Journal of Clinical Oncology ·Antoine Adenis, Guillaume Piessen, Samuel Le Sourd, Emilie Bogart, A. Paumier, V. Vendrely, Olivier Gléhen, Laëtitia Dahan, Jason Dijkhuis, Damien Bergeat, Emmanuelle Samalin, Marion Chauvenet, Xavier Benoît D’Journo, Sandrine Hiret, Caroline Gronnier, D. Maraschio, Diane Pannier, Julie Véziant, Marie‐Cécile Le Deley, X. Mirabel	2023	0
2	SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer Digestive and Liver Disease ·P.A. Bernasconi, Éric François, Thomas Aparicio, Karine Le Malicot, Rabia Boulahssass, Thierry Lecomte, Pierre Laurent‐Puig, Boris Guiu, Éléna Paillaud, Marie‐Pierre Galais, Cl. Dietrich, David Tougeron, Louis-Marie Dourthe, Rosine Guimbaud, Emmanuelle Samalin, Marie Moreau, Christophe Louvet, Côme Lepage, Astrid Lièvre	2022	2
3	The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases Surgery ·Parameswara Reddy Nangi, François Quénet, Marta Jarlier, Luísa Maria Veloso de Andrade Pires Pinto, Gediminas Ma, Sébastien Carrère, Emmanuelle Samalin, Thibault Mazard, Marc Ychou, Olivia Sgarbură, Frédéric Bibeau	2022	0
4	Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature Cancer Treatment Reviews ·Christelle de la Fouchardière, Lore Decoster, Emmanuelle Samalin, C. Terret, Cindy Kenis, Jean‐Pierre Droz, Clélia Coutzac, Elizabeth Smyth	2021	5
5	Le protocole FLOT est-il le nouveau standard de chimiothérapie péri-opératoire des cancers de l’estomac ? Bulletin du Cancer ·Antoine Adenis, Emmanuelle Samalin, Thibault Mazard, Fei Hou, Anne Mourrégot, Marc Ychou	2020	4
6	Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI) Annals of Oncology ·Emmanuelle Samalin, Anthony Turpin, Faïza Khemissa, Aziz Zaanan, M. Benabdelghani, Hélène Senellart, Marine Gilabert, Ludovic Evesque, Laëtitia Dahan, David Sefrioui, Olivier Bouché, Christelle de la Fouchardière, Audrey Hennequin, Laure Monard, Sophie Gourgou, Anthony Lopez	2019	2
7	Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients Annals of Oncology ·Emmanuelle Samalin, Thibault Mazard, Eric Assénat, Dorothy N. Ezenwa, Christelle de la Fouchardière, Rosine Guimbaud, Denis Smith, Katharina Zöller, Marc Ychou, Md. Al Araf, Hélène de Forges, Evelyne Lopez‐Crapez, Simon Thézenas	2019	2
8	Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial Gastric Cancer ·Yann Touchefeu, Rosine Guimbaud, Christophe Louvet, Laëtitia Dahan, Emmanuelle Samalin, Emilie Barbier, Karine Le Malicot, Romain Cohen, J.M. Gornet, Thomas Aparicio, Āśvalāyana, A. Azzedine, Pierre Étienne, 安造计, Pascal Hammel, Nicolas Chapelle, David Sefrioui, Laurent Mineur, Côme Lepage, Olivier Bouché	2018	5
9	Colorectal Cancer in People with Intellectual Disabilities Oncology ·Diane Willis, Emmanuelle Samalin, Daniel Satgé	2018	21
10	Docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: A phase II study of French interdisciplinary GERCOR and FFCD Groups (Epitopes-HPV02 study) Annals of Oncology ·Stéfano Kim, Éric François, Taixuan Wan, Emmanuelle Samalin, Farid El Hajbi, Nabil Baba-Hamed, Sarah Dumont, Simon Pernot, D. Peiffert, François Ghiringhelli, Olivier Bouché, Jérôme Desrame, Mustapha Zoubir, Aurélie Parzy, Denis Smith, Christelle de la Fouchardière, Bruno Buecher, V. Vendrely, Franck Bonnetain, Christophe Borg	2017	1
11	PRODIGE 51 - GASTFOX: Phase III randomised trial evaluating FOLFOX with or without DOCETAXEL (TFOX) as 1st line chemotherapy for locally advanced or metastatic oesophago-gastric adenocarcinoma Annals of Oncology ·Aziz Zaanan, Emmanuelle Samalin, Christophe Louvet, Shiheng Zheng, Faïza Khemissa, Olivier Bouché, Samy Louafi, François Ghiringhelli, Hiroyuki Matsumoto, Benoist Chibaudel, Pascal Artru, Yann Molin, Nabil Baba-Hamed, Paul A. Kuban, Thomas Aparicio, Pierre Michel, P Rougier, David Tougeron, Sylvain Manfrédi, Julien Taı̈eb	2017	4
12	Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects European Journal of Cancer ·Simon Pernot, Cécile Badoual, Magali Terme, Florence Castan, Aurélie Cazes, Olivier Bouché, Jaafar Bennouna, Éric François, François Ghiringhelli, Christelle de la Fouchardière, Emmanuelle Samalin, Jean‐Baptiste Bachet, Christophe Borg, Michel Ducreux, Elie Marcheteau, Trevor Stanbury, Sophie Gourgou, David Malka, Julien Taı̈eb	2017	46
13	Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) Digestive and Liver Disease ·Christophe Locher, А.И. Кузнецова, Pauline Afchain, Nicolas Carrère, Emmanuelle Samalin, Christophe Cellier, Thomas Aparicio, Suresh Ch. Biswas, Laurent Bedenne, Pierre Michel, Yann Parc, Marc Pocard, Benoist Chibaudel, Olivier Bouché	2017	49
14	Perioperative chemotherapy with FOLFOX in resectable gastroesophageal adenocarcinoma in real life practice: An AGEO multicenter retrospective study Digestive and Liver Disease ·Florence Mary, Aziz Zaanan, Valérie Boige, Pascal Artru, Emmanuelle Samalin, Romain Coriat, Jean‐Baptiste Bachet, Marouane Boubaya, Mourad Benallaoua, David Tougeron, Pauline Afchain, Christophe Locher, Isabelle Baumgaertner, Cédric Lecaille, G. Des Guetz, Thomas Aparicio	2016	7
15	Neoadjuvant therapy for gastroesophageal adenocarcinoma World Journal of Clinical Oncology ·Emmanuelle Samalin, Marc Ychou	2016	12
16	Bone metastases in gastrointestinal cancer Clinical & Experimental Metastasis ·Fei Hou, Simon Thézenas, Emmanuelle Samalin, Eric Assénat, Thibault Mazard, Marc Ychou	2014	23
17	Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort Gastric Cancer ·Simon Pernot, Emmanuel Mitry, Emmanuelle Samalin, Laëtitia Dahan, Cécile Dalban, Marc Ychou, Jean‐François Seitz, Camila Oliveira Sousa Santos, Thibault Mazard, Aziz Zaanan, Céline Lepère, Jean-Nicolas Vaillant, Bruno Landi, Philippe Rougier, Julien Taı̈eb	2013	14
18	Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: A pilot comparative study European Journal of Cancer ·Jacqueline Duffour, Simon Thézenas, O. Dereure, Mi young Pyo, Natalia Vilches Cisneros, Emmanuelle Samalin, Fei Hou, Md. Al Araf, Patrick Chalbos, H. Corr, Marc Ychou, B. Guillot	2010	15
19	転移性結腸直腸癌(MCRC)患者の第一線治療としてのFOLFIRINOXと併用したセツキシマブを評価する多施設第二相試験の最終結果 Annals of Oncology ·Emmanuelle Samalin, Françoise Desseigne, Simon Thézenas, Frédéric Bibeau, F. Viret, Laurent Mineur, Eric Assénat, Jean‐Pierre Bleuse, Fei Hou, Evelyne Lopez‐Crapez, Marc Ychou	2009	2
20	Colonic Flat Neoplasia: Frequency and Concordance Between Endoscopic Appearance and Histological Diagnosis in a French Prospective Series The American Journal of Gastroenterology ·Marie-Danièle Diébold, Emmanuelle Samalin, Corinne Merle, Olivier Bouché, Thierry Higuero, Damien Jolly, Tongxin Zhong, I. O. Brod, Evi Steen, Gérard Thiéfin, Guillaume Cadiot	2004	22

About Emmanuelle Samalin

Emmanuelle Samalin is a scholar working on Oncology, Gastroenterology, Pulmonary and Respiratory Medicine, Hepatology and Surgery, having authored 75 papers that have together received 827 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (32 papers), Gastric Cancer Management and Outcomes (30 papers), Cancer Treatment and Pharmacology (16 papers), Pancreatic and Hepatic Oncology Research (15 papers), Lung Cancer Treatments and Mutations (11 papers), Esophageal Cancer Research and Treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). The work is most often cited by research in Gastroenterology (123 citations), Oncology (562 citations), Hepatology (87 citations), Pulmonary and Respiratory Medicine (353 citations) and Cancer Research (114 citations). Emmanuelle Samalin has collaborated with scholars based in France, Belgium and United States. Frequent co-authors include Marc Ychou, Eric Assénat, Fabienne Portales, Simon Thézenas, Thierry Conroy, Michel Ducreux, Céline Gavoille, Julien Taı̈eb, Thibault Mazard and Frédéric Bibeau. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Digestive and Liver Disease, European Journal of Cancer and Gastric Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact